Skip to content

Clinical trials

Tuberous Sclerosis trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Tuberous Sclerosis Country / region: Australia Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20121
20161
20171
20181
20191
20224
20241
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting2
Recruiting2
Terminated2
Available1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GRIN Therapeutics, Inc.3
Longboard Pharmaceuticals3
Marinus Pharmaceuticals2
Novartis Pharmaceuticals2
Dermatology Specialties Limited Partnership1
Jazz Pharmaceuticals1
SAPU NANO (US) LLC1
Sovargen1
Takeda1
The University of Texas Health Science Center, Houston1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Tuberous Sclerosis17
Epilepsies, Myoclonic4
Epilepsy4
Focal Cortical Dysplasia4
Lennox Gastaut Syndrome4
Seizures3
Angiofibroma1
Astrocytoma1
Brain Diseases1
Carcinoma, Hepatocellular1

Trials

Showing 26 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.